Microbiome signatures in prostate cancer
- PMID: 30794288
- DOI: 10.1093/carcin/bgz008
Microbiome signatures in prostate cancer
Abstract
We have established a microbiome signature for prostate cancer using an array-based metagenomic and capture-sequencing approach. A diverse microbiome signature (viral, bacterial, fungal and parasitic) was observed in the prostate cancer samples compared with benign prostate hyperplasia controls. Hierarchical clustering analysis identified three distinct prostate cancer-specific microbiome signatures. The three signatures correlated with different grades, stages and scores of the cancer. Thus, microbiome signature analysis potentially provides clinical diagnosis and outcome predictions. The array data were validated by PCR and targeted next-generation sequencing (NGS). Specific NGS data suggested that certain viral genomic sequences were inserted into the host somatic chromosomes of the prostate cancer samples. A randomly selected group of these was validated by direct PCR and sequencing. In addition, PCR validation of Helicobacter showed that Helicobacter cagA sequences integrated within specific chromosomes of prostate tumor cells. The viral and Helicobacter integrations are predicted to affect the expression of several cellular genes associated with oncogenic processes.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Similar articles
-
The Microbiome and Prostate Cancer Risk.Curr Urol Rep. 2019 Sep 7;20(10):66. doi: 10.1007/s11934-019-0922-4. Curr Urol Rep. 2019. PMID: 31493090 Review.
-
No link between viral findings in the prostate and subsequent cancer development.Br J Cancer. 2007 Jan 15;96(1):137-9. doi: 10.1038/sj.bjc.6603480. Epub 2006 Nov 21. Br J Cancer. 2007. PMID: 17117176 Free PMC article.
-
Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer.J Urol. 2018 Jan;199(1):161-171. doi: 10.1016/j.juro.2017.08.001. Epub 2017 Aug 7. J Urol. 2018. PMID: 28797714 Free PMC article.
-
The ovarian cancer oncobiome.Oncotarget. 2017 May 30;8(22):36225-36245. doi: 10.18632/oncotarget.16717. Oncotarget. 2017. PMID: 28410234 Free PMC article.
-
The microbiome in prostate inflammation and prostate cancer.Prostate Cancer Prostatic Dis. 2018 Sep;21(3):345-354. doi: 10.1038/s41391-018-0041-1. Epub 2018 May 23. Prostate Cancer Prostatic Dis. 2018. PMID: 29795140 Review.
Cited by
-
Effects and mechanisms of Helicobacter pylori infection on the occurrence of extra-gastric tumors.World J Gastroenterol. 2024 Oct 7;30(37):4090-4103. doi: 10.3748/wjg.v30.i37.4090. World J Gastroenterol. 2024. PMID: 39474401 Free PMC article. Review.
-
Contemporary Update on Clinical and Experimental Prostate Cancer Biomarkers: A Multi-Omics-Focused Approach to Detection and Risk Stratification.Biology (Basel). 2024 Sep 25;13(10):762. doi: 10.3390/biology13100762. Biology (Basel). 2024. PMID: 39452071 Free PMC article. Review.
-
Cold and hot tumors: from molecular mechanisms to targeted therapy.Signal Transduct Target Ther. 2024 Oct 18;9(1):274. doi: 10.1038/s41392-024-01979-x. Signal Transduct Target Ther. 2024. PMID: 39420203 Free PMC article. Review.
-
Comparative Study Analysis of Epstein-Barr Virus Infection: Tissue Versus Blood Samples in Patients With Prostatic Adenocarcinoma and Its Correlation With Clinicopathological Parameters.Cureus. 2024 Aug 2;16(8):e66048. doi: 10.7759/cureus.66048. eCollection 2024 Aug. Cureus. 2024. PMID: 39224737 Free PMC article.
-
Influence of diabetes on microbiome in prostate tissues of patients with prostate cancer.Front Oncol. 2024 Aug 16;14:1445375. doi: 10.3389/fonc.2024.1445375. eCollection 2024. Front Oncol. 2024. PMID: 39220653 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical